January 2024

RHEUMATOLOGY

ADVANCING PERSONALIZED MEDICINE: ULTRASOUND-GUIDED SYNOVIAL BIOPSY FOR RHEUMATOID ARTHRITIS TREATMENT

Featuring: Arthur M. Mandelin, MD, PhD

​Arthur M. Mandelin, MD, PhD, associate professor of Rheumatology at Northwestern Medicine, performs an ultrasound-guided synovial biopsy on a patient with rheumatoid arthritis who has reached an inflection point on her current treatment plan and is looking to switch medications. The patient is a part of the REASON (Rheumatoid Arthritis Synovial Tissue Network) study, which will guide physicians to give personalized medicine to each patient from day one of their rheumatoid arthritis diagnosis. The research team hopes that this testing will identify a marker within the joint lining to predict medication outcomes and bring the era of trial-and-error medication switching to an end.
 
Read more about the best practices for ultrasound-guided synovial biopsy here.

YOU MAY ALSO LIKE:
- Ultrasound-Guided Synovial Biopsy: Precision Medicine Meets Rheumatoid Arthritis
- Defining Rheumatoid Arthritis Subtypes May Improve Treatments
- Ultrasound-Guided Synovial Biopsies: Rheumatoid Arthritis Meets Precision Medicine
​
Arthur M. Mandelin, MD, PhD, Associate Professor of Rheumatology at Northwestern Medicine

Refer a Patient

Northwestern Medicine welcomes the opportunity to partner with you in caring for your patients. ​

You May Also Like